Novanta Inc. heads into its May 12 earnings print with a striking internal contradiction: short sellers are building positions at a measured pace while the stock has surged 11% in a week and the CEO has been selling.
The most telling signal is the insider activity. CEO Matthijs Glastra sold roughly $852,000 worth of shares on May 5 — just a week before the print — adding to a $189,000 sale in early March. CFO Robert Buckley followed a similar pattern in mid-March, offloading just over $1.16 million across several transactions. Combined, insiders have been net sellers of more than $4.9 million over the past 90 days. That cluster of C-suite selling, coinciding with the stock's recent rebound toward $140, is hard to ignore heading into a print.
Short interest reinforces the cautious tone from the lending market's perspective. At nearly 12% of the free float, Novanta carries a notably heavy short position — one that has grown steadily for six weeks, rising about 6% from a month ago. Borrow costs remain low at 0.46%, but availability has tightened to its most constrained level of the past year, with the 52-week high in utilization hit on May 8. The ORTEX short score has climbed to 73 — firmly in elevated territory — and days-to-cover of 11.8 suggests any sustained short covering would take significant time to unwind.
Options positioning, however, tells a different story. The put/call ratio has actually eased relative to recent norms, running at 3.09 against a 20-day average of 3.61 — nearly 1.7 standard deviations below that mean. Despite the elevated absolute level of put interest, options traders appear to be pulling back on downside protection into this specific print. That divergence from the short-interest signal is notable: the two positioning signals are not aligned.
The sole analyst on record, Baird's Robert Mason, upgraded Novanta to Outperform in late March — a constructive move, though he simultaneously trimmed his price target to $144 from $150. With the stock now trading near $140, the analyst target implies only modest upside from current levels. The earnings history adds texture: the most recent comparable print in February saw the stock fall 6.4% the following day before partially recovering over the week. The prior print in May 2025 produced a 10.2% one-day gain. The range of outcomes has been wide.
Today's release tests whether Novanta's business fundamentals can justify a stock that has rallied sharply into earnings, against a backdrop where its own executives have been steady sellers and short sellers have been quietly adding to a position that now accounts for roughly one in eight shares of the free float.
See the live data behind this article on ORTEX.
Open NOVT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
